The FDA has announced the formation of a drug shortages task force, which the agency said will address some of the underlying structural concerns that give rise to the recurring supply disruptions that have put such a severe burden on pharmacy operations and patient care.
“We’ve recommitted ourselves to expanding our efforts to identify additional actions to prevent and address shortages and look forward to continuing to work with Congress on these efforts,” Scott